To determine the test-retest reliability and minimum detectable change scores for seven common clinical measurements of muscle strength and physical function in a multiethnic sample of sarcopenic, malnourished men and women. DESIGN: Each participant visited the laboratory seven times over 25 to 26 weeks. Reliability was assessed for each measurement from Familiarization 1 to Familiarization 2 (R1), Familiarization 2 to baseline testing (R2), Familiarization 3 to 12-week testing (R3), and Familiarization 4 to 24-week testing (R4). SETTING: Data were collected during a clinical trial at 23 sites in the United States, Belgium, Italy, Mexico, Poland, Spain, Switzerland, and the United Kingdom. PARTICIPANTS: Sarcopenic, malnourished, older adults (N = 257; n = 98 men aged 76.8 AE 6.3, n = 159 women aged 75.9 AE 6.6). MEASUREMENTS: During each visit, participants completed the Short Physical Performance Battery (SPBB) and isometric handgrip and isokinetic leg extensor and flexor strength testing at a slow (1.05 rad/s) and fast (3.15 rad/s) velocity. RESULTS: Handgrip strength, gait speed, SPPB score, and isokinetic leg extension and flexion peak torque (PT) had intraclass correlation coefficients (ICCs) that were significantly greater than 0 (all ≥0.59) at R1, R2, R3, and R4, although most of these variables demonstrated systematic increases at R1, and several exhibited systematic variability beyond the baseline testing session. CONCLUSION: The ICCs and standard errors of the measurement (SEMs) generally improved with familiarization, which emphasizes the need for at least one familiarization trial for these measurements in sarcopenic, malnourished older adults. A three tier-approach to interpreting the clinical importance of statistically significant results that includes null hypothesis testing, examination and interpretation of the effect magnitude, and comparison of individual changes with the SEM and minimum detectable change of the measurements used is recommended. J Am Geriatr Soc 65:839-846, 2017.
A ging is associated with a progressive loss of skeletal muscle mass and strength known as sarcopenia. Sarcopenia has multiple contributing factors, including chronic disease, a sedentary lifestyle, and malnutrition, and is associated with deleterious consequences such as impaired mobility, impaired ability to perform activities of daily living, greater risk of falls and fractures, loss of independence, and greater risk of death. 1 In 2010, it was estimated that sarcopenia affected more than 50 million people and would affect more than 200 million older adults through 2050. 1 Consequently, the identification and treatment of sarcopenia has become an emphasis of investigators and clinicians worldwide, and identifying reliable measurements with which to identify and track sarcopenia is of great importance.
In 2009, a group of representatives from the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics-European Region, and the International Association of Nutrition and Aging formed the European Working Group on Sarcopenia in Older People (EWGSOP) to develop a clinical definition of and diagnostic criteria for sarcopenia. 1 In its report, the EWGSOP developed primary outcome domains for interventions in sarcopenic older adults that included muscle strength and physical performance. 1 The EWGSOP identified handgrip, leg extensor, and leg flexor strength as three primary muscle strength measurements and the Short Physical Performance Battery (SPPB) and usual gait speed as two primary tests of physical function for use in studies on sarcopenia, 1 but they recognized that information on the feasibility of muscle strength testing was needed from a wider range of ages and ethnicities in older adults. 1 Furthermore, although studies have identified meaningful changes in gait speed and SPPB score in older adults with mild to moderate mobility impairment and older sedentary adults, 2, 3 no previous studies have examined the reliability or of meaningful changes in sarcopenic, malnourished older adults. Therefore, the purpose of this study was to determine the test-retest reliability and minimum detectable change (MDC) scores for seven common clinical measurements of muscle strength and physical function in a multiethnic sample of sarcopenic, malnourished older men and women.
METHODS

Participants
Two hundred fifty-seven men (n = 98; mean age 76.8 AE 6.3, height 171.5 AE 7.4 cm, weight 77.8 AE 13.9 kg) and women (n = 159; mean age 75.9 AE 6.6, height 156.8 AE 7.7 cm, weight 65.1 AE 12.7 kg) completed this study. All participants were aged 65-90 and were ambulatory and had a Subjective Global Assessment of Nutritional Status score of B or C, 4 a gait speed slower than 0.8 m/s or low handgrip strength (<20 kg for women, <30 kg for men), and a low skeletal muscle mass index according to whole-body dual x-ray absorptiometry (Class 1 or Class 2 sarcopenia), 1 which classified them as sarcopenic, malnourished older adults. Further details regarding inclusion and exclusion criteria have been published elsewhere. 5 The institutional review board or ethics committee at each of the study sites approved this study. All participants provided written informed consent before data collection, and a physician's clearance was required to verify all inclusion and exclusion criteria before enrollment.
Experimental Design
Each participant visited the laboratory on seven occasions over 25-26 weeks ( Figure S1 ). At each visit, participants completed handgrip strength testing, the SPPB, and isokinetic leg extension and flexion testing. Reliability was assessed in men and women for each measurement from Familiarization 1 to Familiarization 2 (R1), Familiarization 2 to baseline testing (R2), Familiarization 3 to 12-week testing (R3), and Familiarization 4 to 24-week testing (R4).
These data were collected during a clinical trial (ClinicalTrials.gov Identifier: NCT01191125) from February 2011 to September 2012 at 23 sites in the United States, Belgium, Italy, Mexico, Poland, Spain, Switzerland, and the United Kingdom. Before any testing, all study staff were trained in a webinar and in person. This clinical trial involved two intervention arms comparing an experimental oral nutritional supplement with a control oral nutritional supplement, but the aim of this substudy was to examine the test-retest reliability at each discrete testing phase (R1, R2, R3, R4), and the effects of the intervention arms were not examined, so the intervention did not affect the reliability of these tests reported herein. Baseline isokinetic muscle strength data from this clinical trial have been previously published. 5 
Isometric Handgrip Strength Testing
Maximal isometric handgrip strength was measured using a calibrated hand-held dynamometer (Jamar, Lafayette Instrument, Lafayette, IN). Participants completed three trials during which they were asked to squeeze the dynamometer handle as forcefully as possible for 3 to 5 seconds. Each trial was recorded in kilograms, and the average of three trials was used as the representative score.
Short Physical Performance Battery
The SPPB has been described previously. 6 Each of its components (balance tests, gait speed) were scored on a scale from 0 to 4, and a composite SPPB score was created from all three tests and used for analyses. Individual gait speed times during the 4-m course were converted to m/s and analyzed separately from the composite SPPB score.
Isokinetic Leg Extension Strength Testing
For all isokinetic testing, participants were seated on a calibrated isokinetic dynamometer. They completed four submaximal warm-up leg extension and leg flexion contractions at 25%, 50%, 75%, and 100% of their perceived effort at 1.05 rad/s and 3.14 rad/s. After the warm-ups, each participant completed three maximal leg extension and flexion contractions as quickly and explosively as possible at each velocity. The dynamometer software calculated peak torque (PT; Nm), which was the peak of the isokinetic torque-angle curve for each repetition. The repetition yielding the highest PT value at each velocity for each participant was used for further analysis. 5 
Statistical Analyses
The dependent variables used for analysis were handgrip strength (kg), gait speed (m/s), SPPB score, isokinetic leg extension PT at 1.05 rad/s and 3.14 rad/s (Nm), and isokinetic leg flexion PT at 1.05 rad/s and 3.14 rad/s (Nm).
Before statistical analyses were conducted, the data were checked for data entry errors. Errors or nonphysiological values were found for up to eight subjects, such as values that were outside of the equipment's reporting capabilities. In each instance, all data for that participant were removed for that variable at the corresponding time point. Tables 1-3 indicate where data entry errors were removed (indicated by aˆin the sample size column).
Test-retest reliability was quantified for each of the dependent variables between visits at R1, R2, R3, and R4. Two-way analyses of variance (ANOVAs) were used to compare the means between visits for systematic variability. Cohen's d effect sizes were calculated for the difference in means between visits. The likelihood that the magnitude of the effect was meaningful was determined using magnitude-based inferences using a smallest important effect value of 0.2.
7 Test-retest reliability was calculated by determining the intraclass correlation coefficient (ICC) using model "2, k." 8, 9 The 95% confidence interval (CI) The Cohen's d effect size (ES) and chance that the value of the statistic is trivial (%) for the significant systematic changes are also provided.
for each ICC 2,k was also calculated. 8, 10, 11 For measures of absolute reliability, the standard error of the measurement (SEM) was calculated as the square root of the mean square error from the ANOVA table. 9, 12 The coefficient of variation (CV) was calculated as a normalized measure of the SEM. 12 The MDC was computed by calculating a 95% interval about the SEM using the equation described by Weir. 9 All data were analyzed using SPSS version 22 (IBM, Armonk, NY) and a custom-written spreadsheet (Excel, Microsoft, Redmond, WA). A type I error rate was set a priori at 5%.
RESULTS
The means, standard deviations, and test-retest reliability statistics for the dependent variables at R1, R2, R3, and R4 are provided in Tables 1-3, Table S1 , and Figures S2 and S3. The ICCs for each dependent variable at R1, R2, R3, and R4 were all greater than 0 (P ≤ .05).
DISCUSSION
This is the first study to quantify the test-retest reliability of commonly used clinical assessments of physical function in sarcopenic, malnourished older men and women over 24 weeks. The results indicate that handgrip strength, gait speed, SPPB score, and isokinetic leg extension and flexion PT had ICCs that were greater than 0 (all ≥ 0.59) at all four of the test-retest time points, although most of these variables demonstrated systematic increases at R1, and several of the variables, such as gait speed, SPPB score, and leg flexion PT at 1.05 rad/s, exhibited systematic variability beyond the baseline testing session. Finally, ranges are provided for SEM and MDC scores (Table S1) for each of the tests that may be used to evaluate individual responses to interventions.
All of the variables in the present study demonstrated relative reliability (ICCs) greater than 0 ( Figure S2) at each of the time points assessed, although there were several variables for which the ICCs improved with familiarization. For example, the ICCs for gait speed, SPPB score, and isokinetic leg extension and flexion at 1.05 rad/s improved from R1 and/or R2 to R3 and/or R4 in men. Similarly, the ICCs for gait speed, handgrip strength, and isokinetic leg flexion at 3.14 rad/s improved from R1 and/ or R2 to R3 and/or R4 in women, indicating that familiarization may increase the relative reliability of these variables in sarcopenic, malnourished older men and women.
The ICCs for isokinetic leg flexion in women were generally lower than for isokinetic leg extension (Figure S2 ), and this difference was more evident at 3.14 rad/s than 1.05 rad/s. A previous study 5 demonstrated that the variability in PT over three isokinetic repetitions was greater in sarcopenic, malnourished elderly individuals than in those who were healthy, greater for leg flexion than extension, and greater at 3.14 rad/s than 1.05 rad/s. It also found a significant negative relationship between intraindividual variability and strength. 5 Therefore, it is possible that the lower ICCs for leg flexion PT in the sarcopenic, malnourished women in the present study was a function of lower leg flexion strength. It has been suggested that the inability of older adults to express strength reliably may be a direct consequence of detrimental age-related changes in neuromuscular function, 13, 14 and low leg flexion strength has been associated with greater risk of falls in older adults. [15] [16] [17] Thus, although isokinetic leg flexion strength tests may exhibit lower reliability in sarcopenic, malnourished older adults, increasing leg flexion strength may be a way to enhance physical function in this population.
With the exception of handgrip strength in women, gait speed in men, and isokinetic leg flexion PT at 3.14 rad/s in men, there were systematic increases for each variable from Familiarization 1 to 2 (at R1). Furthermore, gait speed, SPPB score, and leg extension and flexion PT at 1.05 rad/s exhibited systematic variability beyond R1, although as previously described, "(s)upraoptimal sample sizes can produce. . . statistically significant effects that are likely to be clinically useless."
7 Therefore, because of the large sample sizes in this study, magnitude-based inferences were used to measure the clinical meaningfulness of these changes objectively. 7 The magnitude-based inferences indicated that the significant changes (P ≤ .05) in SPPB score at R2 (% chance of indicated outcome (likely or trivial) = 60.0%; outcome = probably trivial), gait speed at R2 (54.3%; probably trivial) and R3 (80.7%; likely trivial), and isokinetic leg flexion PT at 1.05 rad/s at R2 (55.1%; probably trivial) and R4 (69.5%; probably trivial) for women were trivial (Tables 1-3 ). The meaningful systematic changes at R1 further establish the importance of familiarization when using these variables in sarcopenic, malnourished older adults. Finally, the meaningful, systematic changes beyond R1 for variables such as gait speed in men and SPPB score in men and women demonstrate that significant changes in large-scale clinical trials should be interpreted with caution and emphasize the need for a metric that provides a standard for researchers and clinicians to evaluate meaningful changes. In addition, because the SPBB is a composite of several tests, researchers may choose to report the results of the individual tests and the composite SPBB score.
Previous authors have used or suggested the use of the SEM and MDC as indices for investigators seeking to understand the importance of an individual's change based on the precision of the measurement. 2, 18 The SEM provides a quantification of the trial-to-trial noise of a test and has been described as an index that "links the reliability of the measurement. . . to the standard deviation of the population." 9, 18 The MDC is calculated as a 95% confidence interval (CI) about the SEM and has been described as "the difference needed between separate measures on a subject for the difference in the measures to be considered real." 9 In other words, investigators can be 95% confident that an individual's change exceeds the measurement error if the change is equal to or greater than the MDC, although the 95% CI used to calculate the MDC may be too conservative in a clinical setting. For example, a skeletal muscle mass index 1 standard deviation unit below the mean in young adults (a value below the 68% confidence interval) has been used to define Class I sarcopenia, and a value 2 standard deviation units below the mean (a value below the 95% CI) has been used to define Class II sarcopenia in older adults. 1, 19 Consequently, previous investigators have used the SEM as an indicator of clinically meaningful change for individuals on a test. 2, 18 Therefore, in addition to reporting the results of null hypothesis testing, investigators may wish to report the proportion of subjects with improvements that exceeded the SEM as a moderate change and the MDC as a large change. Accordingly, a range of SEM and MDC values have been provided for each of the seven variables examined in this study (Table S1 ) that can be used to assess changes after an intervention on a subject-by-subject basis.
Much like the ICCs, a qualitative examination suggested that the SEM and MDC tended to decrease with greater familiarization (Tables 1-3 ). In addition, MDC for isokinetic leg flexion PT in men and women were large, especially at 3.14 rad/s (Table S1 ), suggesting that the absolute reliability of these measurements may be lower than that of the other measurements examined in this study. Therefore, combined with the low ICCs, isokinetic leg flexion may be unreliable in sarcopenic, malnourished older adults.
Overall, the results of the present study indicated that handgrip strength, gait speed, SPPB score, and isokinetic leg extension and flexion PT had relative reliability scores that were greater than 0 at R1, R2, R3, and R4, although there were systematic increases from Familiarization 1 to Familiarization 2 and the ICCs and SEMs generally improved with familiarization for most of the variables examined ( Figure S4 ). Together, these data emphasize the need for at least one familiarization trial for these measurements in sarcopenic, malnourished older adults. These data also stress the importance of control groups in interventions that use these measurements as outcome variables. Finally, in an attempt to interpret the clinical importance of statistically significant results in clinical trials, a three-tiered approach that includes null hypothesis testing, examination and interpretation of the effect magnitude, and comparison of individual changes relative to the SEM and MDC of the measurements used is recommended.
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